SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Dilip Shanghvi
Rank #88 · Healthcare

Dilip Shanghvi

Pharmaceuticals · India

Net worth$27.1B
Today−$248M
7 days+$293K
30 days+$2.1B

Net worth, last 30 days

Low $24.7BHigh $27.4B

Biography

The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.

The company is India's most valuable listed pharma outfit and gets two-thirds of its $6.1 billion annual revenue from overseas markets.

He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.

Sun Pharma acquired U.S. skin cancer drug maker Checkpoint Therapeutics in May 2025 for $355 million.

In February 2025, his son Aalok was appointed as chief operating officer of Sun Pharma.

Did you know

Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.

Shanghvi 's favorite cuisine is south Indian.

In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals.

Holdings

CompanyTickerSharesValue
Sun Pharma Advanced Research532872-IN207,000,000$39.9B
Sun Pharmaceutical Industries Ltd.524715-IN1,263,100,000$2.40T
Suzlon Energy Ltd.532667-IN315,362,000$11.6B
Private assets & other$1.1B

Public holdings ≈ $2.46T. Holdings may include options and overlap between rows.